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Abbreviations: CpG, cytosine-phosphate-guanine; DNMT, DNA methyltransferase; DDM, DNA demethylase; 
OPRM1, Opioid receptor mu 1; SP1, Specificity protein 1; AP1, Activator protein 1; PKCε, Protein kinase C 
epsilon; CDKL5, Cyclin-dependent kinase-like 5; MOPr, mu opioid peptide receptor; 5-MedC, 5-methyl-2´-
deoxycytidine; dG, 2´-deoxyguanosine; G, guanosine; dA, 2´-deoxyadenosine; T, thymidine; dC, 2´-
deoxycytidine; OD, optical density; NAc, nucleus accumbens; PFC, prefrontal cortex; PP1c, protein 
phosphatase-1 catalytic subunit; fosB, FBJ murine osteosarcoma viral oncogene homolog B; LC-MS, liquid 
chromatography-mass spectrometry; HPLC-UV, high performance liquid chromatography-ultra violet. 
Abstract 
Drug abuse is associated with epigenetic changes, such as histone modifications and DNA 
methylation. The purpose of the present study was to examine the effect of chronic cocaine 
and heroin administration on global DNA methylation in brain and liver. Male, 8 week old, 
C57BL⁄6J mice received heroin in a chronic ‘intermittent’ escalating dose paradigm, or 
cocaine in a chronic escalating dose ‘binge’ paradigm, which mimic the human pattern of 
opioid or cocaine abuse respectively. Following sacrifice, livers and brains were removed and 
DNA was extracted from them. The extracted DNA was hydrolyzed and 2´-deoxycytidine 
and 5-methyl-2´-deoxycytidine were determined by HPLC-UV. The % 5-methyl-2´-
deoxycytidine content of DNA was significantly higher in the brain compared to the liver.  
There were no differences between the control animals and the cocaine or heroin treated 
animals in neither of the tissues examined, which is surprising since cocaine administration 
induced gross morphological changes in the liver. Moreover, there was no difference in the % 
5-methyl-2´-deoxycytidine content of DNA between the cocaine and the heroin treated 
animals. The global DNA methylation status in the brain and liver of mice chronically treated 
with cocaine or heroin remains unaffected, but this finding cannot exclude the existence of 
anatomical region or gene-specific methylation differences. This is the first time that global 
DNA methylation in the liver and whole brain has been studied following chronic cocaine or 
heroin treatment.  
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1. Introduction 
The field of epigenetics has grown fast during the last decade. There is now substantial 
evidence that supports the involvement of epigenetic mechanisms in gene expression 
alterations related to psychiatric disorders, including drug addiction (Haycock, 2009; Kalsi et 
al., 2009; Kovatsi et al., 2011; Lutz, 2008; Malvaez et al., 2009; McQuown and Wood, 2010; 
Nestler, 2008; Renthal and Nestler, 2008, 2009; Tsankova et al., 2007). Drug abuse, as an 
environmental stimulus, can trigger epigenetic changes which result in altered gene 
expression. These changes are heritable and target the epigenome, while the DNA sequence 
remains unaffected (Kovatsi et al., 2011). Epigenetic changes include histone modifications 
(histone methylation, acetylation and phosphorylation) and DNA methylation. DNA 
methylation occurs at the carbon 5 position of the cytosine residue, preferably in the so-called 
CpG islands, which are regions rich in CpG dinucleotides within the DNA molecule. The 
enzymes responsible for the addition of the methyl group are called DNA methyltransferases 
(DNMT1, 2, 3a and 3b) (Kovatsi et al., 2011). For the reverse process of demethylation, the 
formation of 5-hydroxymethylcytosine from 5-methylcytosine is required, which is carried 
out by the ten-eleven translocation proteins (Guo et al., 2011, Dahl et al., 2011). Deaminases 
convert 5-hydroxymethylcytosine to 5-hydroxymethyluracil which is then repaired to 
cytosine by the base excision repair pathway (Guo et al., 2011). Methylation of the DNA has 
been associated with gene silencing, whereas active transcription occurs as a result of 
demethylation (Franco et al., 2008; Kovatsi et al., 2011; Tang and Ho, 2007).  
Drug abuse and addiction have been associated with epigenetic alterations, and 
specifically changes in DNA methylation. For instance, increased DNA methylation was 
observed in the OPRM1 gene in lymphocytes of former heroin users currently on methadone 
maintenance (Nielsen et al., 2009). Maternal exposure to cocaine was found to cause 
methylation of the AP-1 and SP1 binding sites and hyper-methylation of the promoter region 
of PKCε in the fetal rat heart (Meyer et al., 2009; Zhang et al., 2007, 2009), as well as 
changes in the global methylation status of hippocampal pyramidal neurons (Novikova et al., 
2008). Direct exposure to cocaine was found to cause hyper-methylation of the CDKL5 gene 
in the striatum (Carouge et al., 2010).  
Drug abuse has been associated with alterations in gene expression in the brain (Yoo et 
al., 2012). For instance, it was shown that cocaine administration elevates MOPr mRNA 
levels in various brain regions (Yuferov et al., 1999; Yoo et al., 2012). Although it is not yet 
clear to what extent these alterations in gene regulation are controlled by epigenetic 
mechanisms, the fact that these mechanisms are reversible could possibly lead to a powerful 
therapeutic tool (Fragou et al., 2011; Kouidou et al., 2010; Kovatsi et al., 2011).  
We have currently studied the effect of chronic heroin or cocaine administration on 
global DNA methylation in liver and brain. We used chronic “intermittent” escalating dose 
heroin and chronic “binge” escalating dose cocaine administration paradigms in mice, which 
are common in vivo models used to mimic the human pattern of either opioid or cocaine use 
and abuse (Kreek et al., 2002; Muller and Unterwald, 2004; Spanagel, 1995).  
This is the first study to investigate global DNA methylation in this model. The animals 
were culled, the tissues of interest were removed, the DNA was extracted from the tissues 
and global DNA methylation, in terms of % 5-methyl-2´-deoxycytidine content, was 
determined by an HPLC-UV method previously published (Kovatsi et al., 2012).  
 
2. Materials and methods 
 
2.1 Animals  
Eight-week old, male C57BL ⁄ 6J mice (B & K Universal, Hull, UK), weighing 20-25 
g, were individually housed in a temperature- and humidity-controlled room with a 12 h light 
⁄ dark schedule for 1 week before experiments commenced. Food and water were available ad 
libitum. All animals were weighed daily throughout the study. All studies were performed in 
accordance with protocols approved by the Home Office (Animals Act 1986) UK and the 
European Community Council Directive of the 24th Nov 1986 (86 ⁄ 609 ⁄ EEC). 
 
2.2 Chronic heroin administration  
Following acclimatization, intraperitoneal (i.p.) injections of either saline (10 mL⁄kg) or 
heroin were administered to the mice in a chronic ‘intermittent’ escalating dose paradigm to 
mimic a common pattern of self-administration in human heroin abusers (Kreek et al., 2002). 
Animals were randomized into two groups (n=9). Each group received either saline or heroin 
injections for 7 days. Two intraperitoneal injections of saline or heroin were administered 
daily (17.00 and 09.00 h), in accordance with a protocol that has been used as an animal 
model to investigate heroin- and morphine-addictive processes (Bailey et al., 2010; Muller 
and Unterwald, 2004; Spanagel, 1995). The heroin-treated animals received 2 x 1 
mg⁄kg⁄injection on day 1, 2 x 2 mg⁄kg⁄injection on days 2 and 3, 2 x 4 mg⁄kg⁄injection on days 
4 and 5, and 2 x 8 mg⁄kg⁄injection on days 6 and 7. One hour after the last treatment injection, 
animals were killed by decapitation after a 30 s exposure to CO2. Brains and livers were 
rapidly removed, frozen by immersion in liquid nitrogen and stored at -80 °C. 
 
2.3 Chronic cocaine administration 
Following acclimatization, intraperitoneal (i.p.) injections of either saline (4 mL⁄kg) or 
cocaine were administered to the mice in an escalating dose ‘binge’ paradigm as described by 
Bailey et al. (Bailey et al., 2005a, 2005b, 2007, 2008; Schlussman et al., 2005), to mimic a 
common pattern of self administration in human cocaine abusers (Tsukada et al., 1996). 
Animals were randomized into two groups (n=9). Each group received either saline or 
cocaine injections for 14 days. Three intraperitoneal injections of saline or cocaine (1 h apart) 
were administered daily, with the first injection 60 min after the start of the light cycle. The 
cocaine-treated animals received 3 x 15 mg⁄kg⁄day on days 1-4, 3 x 20 mg⁄kg⁄day on days 5-8, 
3 x 25 mg⁄kg⁄day on days 9-12, and 3 x 30 mg⁄kg⁄day on days 13 and 14. One hour after the 
last injection, animals were killed by decapitation after a 30 s exposure to CO2. Brains and 
livers were rapidly removed, frozen by immersion in liquid nitrogen and stored at -80 °C.  
 
2.4 Chemicals and reagents 
Cocaine HCl and heroin were purchased from Sigma-Adrich (Poole, UK). 5-methyl-2´-
deoxycytidine (5-MedC) was purchased from US Biological (Massachusetts, U.S.A.). 
Guanosine (G), 2´-deoxyguanosine (dG), thymidine (T), 2´-deoxycytidine (dC) and 2´-
deoxyadenosine (dA) were obtained from Sigma-Aldrich (Taufkirchen, Germany). Sodium 
acetate and ammonium formate were supplied by Fluka (Taufkirchen, Germany). Calcium 
chloride, sodium succinate, micrococcal nuclease, calf thymus DNA, nuclease P1 and zinc 
chloride were purchased from Sigma-Aldrich (Taufkirchen, Germany). Calf spleen 
phosphodiesterase was supplied by Calbiochem-Merck (Darmstadt, Germany) and Slide-A-
Lyser cassette by Pierce-Thermo Scientific (Illinois, U.S.A.). Proteinase K and RNase T1 
were obtained from Roche (Basel, Switzerland) and RNase A from Novagen-Merck 
(Darmstadt, Germany). The Genomic-tip and the Genomic DNA buffer set were 
manufactured by Qiagen (Düsseldorf, Germany). HPLC grade water, ethanol, methanol and 
hydrochloric acid of analytical grade were obtained from Panreac (Barcelona, Spain). 
Isopropanol was purchased from Riedel-de-Haën, Sigma-Aldrich (Taufkirchen, Germany).  
 
2.5 Preparation of standards 
5-MedC and dC stock standard solutions were prepared by diluting the appropriate 
amount of purchased powder in HPLC grade water. The absorbance of the stock solutions 
was measured at 277 nm for 5-MedC and at 271 nm for dC. The measured absorbances were 
used to calculate the precise concentration of the solutions using the molar absorption 
coefficient, ε (ε = 8500 M-1 cm-1 for 5-MedC and ε = 9000 M-1 cm-1 for dC) (Dawson et al., 
1986). The stock standard solutions were diluted with HPLC grade water to prepare working 
standards with the following concentrations: 0.00625, 0.0125, 0.025, 0.05, 0.1, 0.25, 0.5, 1, 
2.5 and 5 mM for 5-MedC and 0.05, 0.1, 0.25, 0.5 and 1 mM for dC. All standard solutions 
were stored at -20°C and were stable for up to 1 month. 
The appropriate amount of purchased calf thymus DNA was diluted in HPLC grade 
water to prepare a calf thymus DNA solution. The precise concentration of the solution was 
calculated by measuring the absorbance of the solution at 260 nm and assuming that 1 
OD=50 μg/mL double stranded (ds) DNA. Aliquots of 50 μg ds DNA were prepared and 
evaporated to dryness in a speedvac. Aliquots were stored at -20°C. 
 
2.6 DNA Extraction 
Extraction of the DNA was carried out using the Qiagen DNA Buffer set and the 
Qiagen genomic tip. All tissues were weighted (100-500 mg used) and homogenized in 19 
mL of Buffer G2 (800 mM guanidine hydrochloride, 30 mM Tris-Cl, pH 8.0, 30 mM EDTA, 
pH 8.0, 5% Tween 20, 0.5% Triton X-100). 250 μL of RNase A (10 mg/mL) and RNase T1 
(100 U) were added and the homogenate was incubated at 37 °C for 30 min. 500 μL of 
Proteinase K (25 mg/mL) were then added and the incubation was continued for an additional 
2.5 h. The tip was equilibrated with 10 mL of Buffer QBT (750 mM NaCl, 50 mM MOPS, 
pH 7.0, 15% v/v isopropanol, 0.15% v/v Triton x-100) and the homogenate was then loaded 
onto it. The tip was subsequently washed with 2 x 15 mL Buffer QC (1.0 M NaCl, 50 mM 
MOPS, pH 7.0, 15% v/v isopropanol) and the DNA was eluted with 15 mL of Buffer QF 
(1.25 M NaCl, 50 mM Tris-Cl, pH 8.5, 15% v/v isopropanol). Cold isopropanol (10.5 mL) 
was added and the sample was centrifuged twice at 4000 rpm and at 4 °C for 25 min, always 
keeping the pellet. The pellet (DNA) was washed initially with ethanol and then with 70% 
ethanol/30% HPLC grade water. The DNA was dried and then reconstituted with 100 μL 
HPLC grade water for liver samples and 200 μL for brain samples. The reconstituted DNA 
was left on a rotating table overnight at room temperature to dissolve and its concentration 
and purity were determined the next day on an Ampliquant AQ-07 photometer at 260 and 
280 nm. Appropriate amounts of DNA were aliquoted into Eppendorf tubes to give 50, 100 
and 200 μg of DNA. The tubes were subjected to speedvac evaporation till dryness and stored 
at -80 °C.  
 
2.7 DNA hydrolysis  
Calf spleen phosphodiesterase (0.001 U/μL, prepared by dialysis using the Slide-A-
Lyser cassette), micrococcal nuclease (0.4 U/μL) and digestion buffer (100 mM sodium 
succinate, 50 mM CaCl2, pH 6.0) were added to the dried DNA aliquots (containing 50 μg 
DNA) and were incubated at 37°C overnight. Nuclease P1 (2 U/μL) was added to the samples 
and the incubation was continued for an additional 4 h. The hydrolyzed DNA was then 
centrifuged at 14,000 rpm for 20 min and the supernatant was evaporated to dryness in a 
speedvac. 25 μL HPLC grade water were added to the samples, to yield a final DNA 
concentration of 2 μg/μL and the samples were stored at -20 °C for less than one week, until 
they underwent HPLC-UV analysis. 
 
2.8 Instrumentation and chromatography  
HPLC analysis was performed on a liquid chromatograph (Shimadzu Prominence) 
coupled with a Diode Array UV detector (Shimadzu SPD-M20A, Kyoto, Japan). Separation 
was achieved on a C18 Phenomenex Synergi Fusion-RP 80A (4 μm, 250 mm × 2.0 mm) 
column, which was attached to a guard column (C18 Synergi Fusion-RP 80A, 4 μm, 4.0 mm 
× 2.0 mm) and a Krudkatcher filter (0.5 μm) (California, U.S.A.). 
The mobile phase consisted of Solvent A (50 mM ammonium formate, pH 5.4) and 
Solvent B (HPLC grade methanol). The gradient time program used was: solvent B 2% at 0 
min, solvent B 3% at 18 min, solvent B 27% at 25 min, solvent B 35% at 40 min, solvent B 
2% at 45 min. Total analysis time was 50 min. The flow rate was set at 0.2 mL/min and the 
column oven temperature was maintained at 25°C. UV detection was carried out at 277 nm. 
 
2.9 Calculation of global DNA methylation 
Global DNA methylation was expressed as the percentage of 5-MedC against the total 
cytosine present in the DNA and was calculated using the following equation:  
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2.10 Statistical Analysis 
All statistical analyses were carried out using the SPSS software v. 18. The Mann-
Whitney U test was used, with a confidence interval of 95 %.  
 
3. Results 
Four groups of animals (n=9) were used in this study. Both for the cocaine and the 
heroin treated animals, an equal number of control animals receiving saline were used.   
For DNA extraction, only a part (100-500 mg) of liver was used. On the other hand, in 
the case of brain, the whole organ was used for DNA extraction. The amount of DNA 
extracted was always sufficient, with a good purity index.  
The hydrolysis and HPLC-UV analysis were carried out in batches of five samples, 
accompanied by a control calf thymus DNA each time. Commercially available calf thymus 
DNA was used as a positive control to ensure that both the hydrolysis and the HPLC-UV 
procedure were effective for every batch (Mean % 5-MedC 6.7%, SD 0.2%, RSD 3.2 %). 
The hydrolysis was a two day process and the samples underwent HPLC-UV analysis on the 
third day, with the exception of samples prepared on Friday, which were analyzed on the fifth 
day. In this way, hydrolyzed DNA remained at -20 °C, prior to HPLC analysis, for a limited 
period of time (less than one week). This special care was necessary and was taken because 
we have previously shown that hydrolyzed DNA is less stable compared to non-hydrolyzed 
DNA when stored at -20 °C (Kovatsi et al., 2012).  
Representative chromatograms of DNA extracted from liver and brain tissues of 
cocaine and heroin treated animals, as well as a representative chromatogram of calf thymus 
DNA are shown in Fig. 1. Zoomed in areas on each chromatogram (A, B, C, D, E) in Figure 
1 depict the chromatographic separation between 5-MedC and guanosine.  
The mean % 5-MedC content of the DNA isolated from the studied tissues, as well as 
the p values corresponding to the statistical comparison between different groups of animals 
are shown in Table 1.  
In cocaine treated animals, the mean % 5-MedC content of liver DNA (4.6% ± 0.3) was 
identical to that of control animals receiving saline (4.6% ± 0.2). Results were similar in the 
brain, where both in the cocaine treated and the control animals the DNA had a mean % 5-
MedC content of 4.9% ± 0.1 (Table 1). Statistical analysis revealed no significant difference 
in the % 5-MedC content of liver (p = 0.583) and brain (p = 0.887) DNA between the cocaine 
treated and the control animals. 
Similarly, in heroin treated animals, the mean % 5-MedC content of liver DNA (4.5% ± 
0.0) was identical to that of control animals receiving saline (4.5% ± 0.1) and the mean % 5-
MedC content of brain DNA (4.9% ± 0.1) was identical to that of control animals receiving 
saline (4.9% ± 0.1). As expected, statistical analysis revealed no significant difference in the 
% 5-MedC content of liver (p = 0.903) and brain (p = 0.837) DNA between the heroin treated 
and the control animals. 
When different tissues were compared, a statistically significant difference in the % 5-
MedC content of DNA between liver and brain was found (Table 2). In all cases, the % 5-
MedC content of DNA was significantly higher in the brain, compared to the liver.  
 
4. Discussion 
Although animals treated with an identical cocaine administration protocol are known 
to exhibit profound alterations in locomotor behavior and stereotypy and profound changes in 
gene expression in several brain regions (Bailey et al., 2005a, 2005b, 2007, 2008, 2010; 
Schlussman et al., 2005; Yoo et al., 2012), we found no changes in the global DNA 
methylation status in either brain or liver, in cocaine treated animals.  
The lack of global DNA methylation alterations induced in the liver by cocaine is 
surprising considering the severe toxic effect that cocaine has on the liver. Indeed, the livers 
of cocaine treated animals were significantly larger (in terms of % weight of liver relative to 
body weight) compared to the livers of saline treated animals (6.12 ± 0.50 % vs 4.27 ± 0.26 
%, p<0.001). Furthermore, gross pathology of the livers of cocaine treated animals revealed 
regions of necrosis and intense eosinophilia (data not shown). Based on the above, we believe 
that the lack of overall DNA methylation changes in the liver observed in our study can be 
attributed to the cancelling out of hyper- and hypo- methylation in different anatomical 
regions of the liver, or in different genomic sites. 
This is the first study to investigate the epigenetic effects of cocaine on liver. On the 
other hand, there is a large body of literature demonstrating profound DNA methylation 
alterations in liver pathology. For instance, global DNA hypo-methylation has been reported 
in liver injury induced by Wilson’s disease (Medici et al., 2012), as well as in liver cells 
following treatment with triclosan, which is thought to cause liver tumors (Ma et al., 2013). 
Furthermore, it has been shown that hypo-methylation plays a crucial role in the onset of liver 
fibrosis and the progression of the disease to cancer (Komatsu et al., 2012). Genomic DNA 
hypo-methylation is also thought to provide a molecular mechanism for the role of hypoxia in 
hepatocellular carcinoma (Liu et al., 2011). Hypo-methylation has also been reported as a 
result of exposure to furan and has been linked to tumors induced by this carcinogen (Chen et 
al., 2012). On the other hand, cadmium has been found to increase global gene methylation in 
the liver of rats and this effect has been linked to increased apoptosis and the onset of 
neoplastic lesions (Wang et al., 2012). Another environmental pollutant, perfluorooctanoic 
acid, has been found to cause dose-dependent hyper-methylation of the glutathione-S-
transferase Pi promoter in human liver cells (Tian et al., 2012a). Global DNA hyper-
methylation has been also linked to fibroblast activation during liver fibrogenesis (Tao et al., 
2011a), while hyper-methylated genes have also been found in hepatocellular carcinoma (Tao 
et al., 2011b).  
In contrast to the liver, there is a large body of literature on the effects of cocaine on 
DNA methylation in the brain. However, these studies have focused on DNA methylation 
either on particular brain regions, such as the nucleus accumbens (NAc) (Anier et al., 2010; 
LaPlant et al., 2010), the hippocampal pyramidal neurons (Novikova et al., 2008), the 
striatum (Carouge et al., 2010) and the prefrontal cortex (PFC) (Tian et al., 2012b), or on 
specific genes, such as the protein phosphatase-1 catalytic subunit (PP1c) promoter, the fosB 
promoter (Anier et al., 2010), the cyclin-dependent kinase-like 5 (CDKL5) gene (Carouge et 
al., 2010) and not the whole genome (global methylation). For instance, it was shown that the 
PFC exhibits hypo-methylation, while the striatum of the brain exhibits hyper-methylation in 
response to chronic cocaine exposure in mice and rats (Carouge et al., 2010; Tian et al., 
2012b). Moreover, it was shown that the methylation status of different genome sites may 
differ within the same anatomical brain region. For instance, in the NAc of mice exposed to 
cocaine, DNA hyper-methylation was observed at the PP1c promoter, while hypo-
methylation was observed at the fosB promoter (Anier et al., 2010). In the offspring of rats 
which were treated with cocaine during gestation, global hypo-methylation in the 
hippocampal pyramidal neurons was observed, whereas, when individual CpG islands were 
examined, 34 % were found to be hyper-methylated and 66 % were found to be hypo-
methylated (Novikova et al., 2008).  
The overall unaffected DNA methylation status observed in our study could be 
attributed to the fact that the whole brain, rather than specific anatomical regions, was 
studied. Hyper- or hypo-methylation in some regions could be counter balanced by hypo- or 
hyper-methylation respectively in other regions, yielding an overall unchanged methylation 
status. Moreover, as global methylation was studied, it is possible that hyper-methylation of 
specific genome sites might have cancelled out the hypo-methylation of other genome sites, 
resulting in lack of global DNA methylation changes overall.  
The protocol of chronic heroin administration currently used is known to induce 
profound alterations in locomotor behavior and gene expression in brains of mice (Bailey et 
al., 2010). Nevertheless, according to our results, in the liver and brain of mice treated with 
this protocol, global DNA methylation remained unaffected. Only one study has been 
published so far on the effect of heroin on DNA methylation, showing hyper-methylation of 
the OPRM1 gene promoter in lymphocytes of former heroin addicts currently on methadone 
maintenance (Nielsen et al., 2009). The present study is the first to investigate the effect of 
chronic heroin treatment on global DNA methylation, in either brain or liver. Our findings 
suggest that there is no observable change in the global DNA methylation status in these 
tissues following chronic heroin treatment in mice. It is possible however, as with the case of 
cocaine, that hyper- and hypo-methylation cancel out in different anatomical regions or in 
different genome sites, therefore resulting in no observable change in the overall DNA 
methylation status.  
When the global DNA methylation status was compared between different tissues, in 
all cases the % 5-MedC content of DNA was statistically higher in the brain, compared to the 
liver. Our findings are in agreement with a previous report which showed that the methyl 
cytosine content of DNA was higher in the brain compared to the liver, both in control as 
well as in haloperidol treated rats (Shimabukuro et al., 2006). Furthermore, another report 
showed that in fetal baboons global DNA methylation was higher in the brain (frontal cortex) 
compared to the liver (Unterberger et al., 2009).  
 
5. Conclusions 
This study aimed at evaluating the effect of chronic heroin and cocaine administration 
on global DNA methylation on the tissue level. Although tissue-specific differences were 
observed, the global DNA methylation status in the brain and liver of mice treated 
chronically with cocaine or heroin remained unaffected. It is possible that hyper- and hypo-
methylation cancel out in different anatomical regions or in different genome sites, resulting 
in an overall unchanged global DNA methylation status, but this is an assumption that 
remains to be elucidated in the future. Further research on different anatomical regions and 
different genomic sites, as well as on key enzymes such as DNMTs will aid towards this 
direction. 
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Figure Legends 
 
Fig. 1. Chromatograms 
 A. Hydrolyzed DNA extracted from the liver of a cocaine-treated mouse.  
B. Hydrolyzed DNA extracted from the brain of a cocaine-treated mouse.  
C. Hydrolyzed DNA extracted from the liver of a heroin-treated mouse.  
D. Hydrolyzed DNA extracted from the brain of a heroin-treated mouse.  
E. Hydrolyzed C.T. DNA used as positive control.  
5-MedC, 5-methyl-2´-deoxycytidine; dG, 2´-deoxyguanosine; G, guanosine; dA, 2´-
deoxyadenosine; T, thymidine; dC, 2´-deoxycytidine   
 Table 1: Comparison between different groups of animals 
Mean % 5-MedC content of the DNA isolated from the studied tissues, standard deviation 
(SD), relative standard deviation (RSD) and p values corresponding to the statistical 
comparison between different groups of animals. 
 
 
Table 2: Comparison between different tissues  
Mean % 5-MedC content of the DNA isolated from the studied tissues, standard deviation 
(SD), relative standard deviation (RSD) and p values corresponding to the statistical 
comparison between different tissues. 
 
Tissue - Experiment Liver - Cocaine Brain - Cocaine Liver - Heroin Brain - Heroin 
Drug Exposure Cocaine Control Cocaine Control Heroin Control Heroin Control 
Mean % 5-MedC 4.6 4.6 4.9 4.9 4.5 4.5 4.9 4.9 
SD (%) 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.1 
RSD (%) 5.7 4.2 1.6 3.0 1.0 2.0 1.7 2.2 
p value (95%) 0.583 0.887 0.903 0.837 
Tissue - Experiment Liver  Brain Liver Brain Liver Brain Liver Brain 
Drug Exposure Cocaine Control Cocaine Treated Heroin Control Heroin Treated 
Mean % 5-MedC 4.6 4.9 4.6 4.9 4.5 4.9 4.5 4.9 
SD (%) 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 
RSD (%) 4.2 3.0 5.7 1.6 2.0 2.2 1.0 1.7 
p value (95%) 0.009 0.005 < 0.005 < 0.005 
